Riskpilot← Back to searchSign inGet full accessKLART SYN BODØ AS
ASActiveOrg 980066746Central Atrium Dronningens Gate 18, 8006 BodøMedical specialists activities · NACE 8622Est. 19980 employees
Revenue 2021
NOK 1,9M
+25% vs 2020
EBITDA margin
24.9%
+81% vs 2020
Equity ratio
99.7%
Financial strength
Net profit 2021
NOK 485K
+82% vs 2020
| Revenue | NOK 1,9M | +25% |
| EBITDA | NOK 484K | +81% |
| Net profit | NOK 485K | +82% |
| Total assets | NOK 1,7M | +145% |
| Equity | NOK 1,7M | +195% |
| Employees | 0 | — |
Legal name
KLART SYN BODØ AS
Org number
980066746
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
13. august 1998
Share capital
NOK 200 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg
Company purpose
Selskapets formål er øyekirurgi og det som naturlig hører hertil, investeringer i verdipapirer og fast eiendom.
Address
Central Atrium Dronningens Gate 18, 8006 Bodø
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1 217 | 1 221 | 944 | 1 565 | 1 949 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 284 | 90 | 72 | 268 | 484 |
| Depreciation & amort. | −455 | −272 | −0 | −1 | −0 |
| EBIT | −171 | −183 | 72 | 267 | 484 |
| Net financials | −3 | −1 | −1 | −1 | 0 |
| Profit before tax | −174 | −184 | 71 | 266 | 485 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −174 | −184 | 71 | 266 | 485 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 525 | 306 | 513 | 688 | 1 689 |
| Equity | 417 | 233 | 304 | 570 | 1 684 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 108 | 73 | 209 | 118 | 5 |
| Total debt | 108 | 73 | 209 | 118 | 5 |
EBITDA margin
24.9%
This company
15.8%
Market median
+58% vs market
20172021
Equity ratio
99.7%
This company
38.2%
Market median
+161% vs market
20172021
Return on equity
28.8%
This company
18.4%
Market median
+57% vs market
20172021
Net profit margin
24.9%
This company
8.1%
Market median
+207% vs market
20172021
Asset turnover
1.15×
This company
1.12×
Market median
+3% vs market
20172021
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20172021
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
PK Chief Executive Officer | Chief Executive Officer | 1998 – 2022 |
MJ Deputy Member | Deputy Member | 2015 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2022 | |
| Former (2) | ||
| Board of Directors | 2015 – 2022 | |
| Board of Directors | 2015 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KLART SYN BODØ AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Kristian Lund | Chief Executive Officer | 0 companies |
| Marit Jørgensen Lund | Deputy Member | 0 companies |
| David Simonsen | Chairman | 0 companies |
| Knut Erik Hansen | Board of Directors | 0 companies |
| Elisabeth Neergaard Blix | Board of Directors | 0 companies |